doripenem has been researched along with Neutropenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
| Farnum, C; Havlichek, DH; Kalra, A; Kulhanek, G; Kuti, JL; Nicolau, DP; Scharmen, A; Smith, CL; Stein, GE; Tran, M | 1 |
| Akiyama, N; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
1 trial(s) available for doripenem and Neutropenia
| Article | Year |
|---|---|
Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia; Young Adult | 2012 |
2 other study(ies) available for doripenem and Neutropenia
| Article | Year |
|---|---|
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors | 2013 |
Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Liver; Male; Middle Aged; Neutropenia; Prospective Studies; Sepsis | 2012 |